AIMS: The role of scavenger receptors in atherogenesis is controversial as a result of conflicting reports and a recent hypothesis suggesting that scavenger receptor absence would enhance the pro-inflammatory, pro-atherogenic milieu. This study addresses the effect of combined absence of scavenger receptors CD36 and SRA I/II on atherosclerosis lesion development in the apolipoprotein E knock-out (apoE degrees ) model. METHODS: We created background-related strains of apoE degrees , scavenger receptor A I/II knock-out (SRA degrees )/apoE degrees , CD36 knock-out (CD36 degrees )/apoE degrees , and CD36 degrees /SRA degrees /apoE degrees mice that were >99% C57Bl/6. Four-week-old mice were fed a Western diet for 12 weeks and were assessed for lesion burden/morphology, risk factors for atherosclerosis, inflammatory mediators, and macrophage function. RESULTS: There was a 61 and 74% decrease in total aortic lesion area in CD36 degrees /apoE degrees males and females, respectively, compared with apoE degrees controls. The absence of SRA was protective (32% decrease in lesion) in female mice. The combined absence of CD36 and SRA provided no further protection in either gender. Macrophages from mice lacking CD36 had decreased pro-inflammatory characteristics and less migration to a pro-inflammatory stimulus. Plasma levels of cytokines/chemokines showed that CD36 degrees /apoE degrees and CD36 degrees /SRA degrees /apoE degrees mice had a less pro-inflammatory phenotype compared with apoE degrees and SRA degrees /apoE degrees mice. Oblivious mice in the apoE degrees background ruled out potential 'passenger gene' effects in the case of CD36. CONCLUSION: These results provide new insights into the pro-atherogenic mechanisms of CD36 by implicating processes other than modified lipoprotein uptake.
AIMS: The role of scavenger receptors in atherogenesis is controversial as a result of conflicting reports and a recent hypothesis suggesting that scavenger receptor absence would enhance the pro-inflammatory, pro-atherogenic milieu. This study addresses the effect of combined absence of scavenger receptors CD36 and SRA I/II on atherosclerosis lesion development in the apolipoprotein E knock-out (apoE degrees ) model. METHODS: We created background-related strains of apoE degrees , scavenger receptor A I/II knock-out (SRA degrees )/apoE degrees , CD36 knock-out (CD36 degrees )/apoE degrees , and CD36 degrees /SRA degrees /apoE degrees mice that were >99% C57Bl/6. Four-week-old mice were fed a Western diet for 12 weeks and were assessed for lesion burden/morphology, risk factors for atherosclerosis, inflammatory mediators, and macrophage function. RESULTS: There was a 61 and 74% decrease in total aortic lesion area in CD36 degrees /apoE degrees males and females, respectively, compared with apoE degrees controls. The absence of SRA was protective (32% decrease in lesion) in female mice. The combined absence of CD36 and SRA provided no further protection in either gender. Macrophages from mice lacking CD36 had decreased pro-inflammatory characteristics and less migration to a pro-inflammatory stimulus. Plasma levels of cytokines/chemokines showed that CD36 degrees /apoE degrees and CD36 degrees /SRA degrees /apoE degrees mice had a less pro-inflammatory phenotype compared with apoE degrees and SRA degrees /apoE degrees mice. Oblivious mice in the apoE degrees background ruled out potential 'passenger gene' effects in the case of CD36. CONCLUSION: These results provide new insights into the pro-atherogenic mechanisms of CD36 by implicating processes other than modified lipoprotein uptake.
Authors: Maria E Bamberger; Meera E Harris; Douglas R McDonald; Jens Husemann; Gary E Landreth Journal: J Neurosci Date: 2003-04-01 Impact factor: 6.167
Authors: Vidya V Kunjathoor; Maria Febbraio; Eugene A Podrez; Kathryn J Moore; Lorna Andersson; Stephanie Koehn; Jeongmi S Rhee; Roy Silverstein; Henry F Hoff; Mason W Freeman Journal: J Biol Chem Date: 2002-10-09 Impact factor: 5.157
Authors: Kathryn J Moore; Joseph El Khoury; Lea A Medeiros; Kinya Terada; Changiz Geula; Andrew D Luster; Mason W Freeman Journal: J Biol Chem Date: 2002-09-17 Impact factor: 5.157
Authors: A Chawla; W A Boisvert; C H Lee; B A Laffitte; Y Barak; S B Joseph; D Liao; L Nagy; P A Edwards; L K Curtiss; R M Evans; P Tontonoz Journal: Mol Cell Date: 2001-01 Impact factor: 17.970
Authors: Joseph B El Khoury; Kathryn J Moore; Terry K Means; Josephine Leung; Kinya Terada; Michelle Toft; Mason W Freeman; Andrew D Luster Journal: J Exp Med Date: 2003-06-09 Impact factor: 14.307
Authors: Kamran Anwar; Iryna Voloshyna; Michael J Littlefield; Steven E Carsons; Peter A Wirkowski; Nadia L Jaber; Andrew Sohn; Sajan Eapen; Allison B Reiss Journal: Lipids Date: 2010-12-22 Impact factor: 1.880
Authors: Allison B Reiss; David W Wan; Kamran Anwar; Joan T Merrill; Peter A Wirkowski; Nidhi Shah; Bruce N Cronstein; Edwin S L Chan; Steven E Carsons Journal: Exp Biol Med (Maywood) Date: 2009-01-14
Authors: David J Kennedy; Sai D Kuchibhotla; Ella Guy; Young Mi Park; George Nimako; DiFernando Vanegas; Richard E Morton; Maria Febbraio Journal: Arterioscler Thromb Vasc Biol Date: 2009-07-16 Impact factor: 8.311